Document Actions
Vicky Leventaki, M.D. - Pathology Resident
Vicky Leventaki, M.D.
Rank: PGY- 3
Residency Program: AP/CP
Professional Education
- 2007, Postdoctoral Fellowship, Department of Hematopathology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas
- 2004, M.D. University of Athens, Athens, Greece
Presentations
- Monoclonal B-Cell Population in Reactive Follicular Hyperplasia, Poster, XXVII International Congress of the International Academy of Pathology, Athens, Greece, October 15, 2008
- Concominant B-CLL and Multiple Myeloma Present as Two Distinct Neoplastic Disorders, Poster, XXVII International Congress of the International Academy of Pathology, Athens, Greece, October 15, 2008
- Expression of Cyclins D1, D2 and D3 in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Poster, 96th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, March, 2007
- Expression of HDM4 (HDMX) in Hodgkin Lymphoma (HL), Poster, 96th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, March, 2007
- Differential Expression of the Id2 Helix-Loop-Helix Protein in T-cell Lymphomas, Poster, 96th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, March, 2007
- Histological and Immunophenotypical Characterization of Angioimmunoblastic T-cell Lymphoma (AILT) Involing the Bone Marrow, Poster, 96th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, March, 2007
- NPM-ALK Promotes Cell Cycle Progression through Activation of JNK in Anaplastic Large Cell Lymphoma, Poster, 48th American Society of Hematology Annual Meeting, December, 2006
- c-Jun Expression is Restricted to CD30-positive Lymphoproliferative Disorders, Poster, 13th Meeting of the European Association for Hematopathology, October, 2006
- cFLIP Overexpression Protects Tumor Cells from Fas-Induced Apoptosis in Pancreatic Adenocarcinoma, Poster, 59th Society of Surgical Oncology Annual Cancer Symposium, March, 2006
- Expression of mTOR Signaling Proteins in Mantle Cell Lymphoma, Platform, 95th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, February, 2006
- Expression of the Id2 Helix-Loop-Helix Protein in Hodgkin and Non-Hodgkin Lymphomas, Poster, 95th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, February, 2006
- Abnormal Cytoplasmic Localization of ARF in Acute Myeloid Leukemia (AML) with NPM Gene Mutations, Poster, 95th United States and Canadian Academy of Pathology (USCAP) Annual Meeting, February, 2006
- cJun is Phosphorylated at Ser73 and Contributes to Cell Cycle Progression in Anaplastic Large Cell Lymphoma, Poster, 47th American Society of Hematology Annual Meeting, December, 2005
- Inhibition of AKT/mTOR Signaling Pathway Induced Cell Cycle Arrest and Apoptosis in Acute Myelogenous Leukemia, Poster, 47th American Society of Hematology Annual Meeting, December, 2005
- Correlation of SOCS3 Expression with STAT3 Activation in Mantle Cell Lymphoma (MCL), Poster, 92nd United States and Canadian Academy of Pathology (USCAP) Annual Meeting, January, 2003
- Loss of Retinoblastoma Protein Expression in Anaplastic Large Cell Lymphoma (ALCL) Cell Lines and Tumors, Poster, 91st United States and Canadian Academy of Pathology (USCAP) Annual Meeting, February, 2002
- Expression of Apoptotic Proteins in Follicular Lymphoma, Poster, 91st United States and Canadian Academy of Pathology (USCAP) Annual Meeting, February, 2002
Publications
- Drakos E, Rassidakis GZ, Leventaki V, Cotta CV, Vega F, Medeiros LJ. Nodular Lymphocyte Predominant Hodgkin Lymphoma With Clusters of LP Cells, Acute Inflammation, and Fibrosis: A Syncytial Variant. Am J Surg Pathol. 2009 Aug 28.
- Inamdar KV, Romaguera JE, Drakos E, Knoblock RJ, Garcia M, Leventaki V, Medeiros LJ, Rassidakis GZ. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine. Cancer. 2009 Aug 25.
- Chen W, Konoplev S, Medeiros LJ, Koeppen H, Leventaki V, Vadhan-Raj S, Jones D, Kantarjian HM, Falini B, Bueso-Ramos CE. Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. Cancer. 2009 Aug 11.
- Drakos E, Atsaves V, Li J, Leventaki V, Andreeff M, Medeiros LJ, Rassidakis GZ. Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. Leukemia. 2009 Apr;23(4):784-90.
- Cotta CV, Leventaki V, Atsaves V, Vidaki A, Schlette E, Jones D, Medeiros LJ, Rassidakis GZ. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. Cancer. 2008 Feb 1;112(3):552-61.
- Drakos E, Thomaides A, Medeiros LJ, Li J, Leventaki V, Konopleva M, Andreeff M, Rassidakis GZ. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. Clin Cancer Res. 2007 Jun 1;13(11):3380-7.
- Leventaki V, Drakos E, Medeiros LJ, Lim MS, Elenitoba-Johnson KS, Claret FX, Rassidakis GZ. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. Blood. 2007 Sep 1;110(5):1621-30.
- Drakos E, Leventaki V, Schlette EJ, Jones D, Lin P, Medeiros LJ, Rassidakis GZ. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. Am J Surg Pathol. 2007 Mar;31(3):447-53.
- Drakos E, Rassidakis GZ, Leventaki V, Guo W, Medeiros LJ, Nagarajan L. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas. Hum Pathol. 2007 Mar;38(3):500-7.
- Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol. 2006 Dec;169(6):2171-80.
- Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret FX, Rassidakis GZ. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 2006 Jul 1;66(13):6589-97.
- Oyarzo MP, Medeiros LJ, Atwell C, Feretzaki M, Leventaki V, Drakos E, Amin HM, Rassidakis GZ. c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma. Blood. 2006 Mar 15;107(6):2544-7.
- Lai R, Leventaki V, Rassidakis GZ. Rust et al. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. J Pathol 2005;206:445-450. J Pathol. 2005 Nov;207(3):372-3; author reply 374-5.
- Amin HM, McDonnell TJ, Ma Y, Lin Q, Fujio Y, Kunisada K, Leventaki V, Das P, Rassidakis GZ, Cutler C, Medeiros LJ, Lai R. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene. 2004 Jul 15;23(32):5426-34.
- Khoury JD, Medeiros LJ, Rassidakis GZ, Yared MA, Tsioli P, Leventaki V, Schmitt-Graeff A, Herling M, Amin HM, Lai R. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3692-9.
- Amin HM, Medeiros LJ, Ma Y, Feretzaki M, Das P, Leventaki V, Rassidakis GZ, O'Connor SL, McDonnell TJ, Lai R. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene. 2003 Aug 21;22(35):5399-407.
- Amin HM, McDonnell TJ, Medeiros LJ, Rassidakis GZ, Leventaki V, O'Connor SL, Keating MJ, Lai R. Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med. 2003 Apr;127(4):424-31.
- Lai R, Rassidakis GZ, Medeiros LJ, Leventaki V, Keating M, McDonnell TJ. Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours. J Pathol. 2003 Jan;199(1):84-9.